{
    "clinical_study": {
        "@rank": "42016", 
        "arm_group": [
            {
                "arm_group_label": "High Nitrogen", 
                "arm_group_type": "Experimental", 
                "description": "In this arm, daily nitrogen supply is as much as 2.5-3.0 g per kilogram (ideal body weight)"
            }, 
            {
                "arm_group_label": "conventional nitrogen", 
                "arm_group_type": "Active Comparator", 
                "description": "In this arm, daily nitrogen supply is 1.2-1.5g per kilogram (ideal body weight) as recommended by ESPEN guideline"
            }
        ], 
        "brief_summary": {
            "textblock": "The patients with sepsis are in high risk of malnutrition, which could contribute to\n      infection, difficulty in weaning from ventilators. The investigators speculate whether\n      nutrition therapy with high nitrogen could attenuate the malnutrition status and improve the\n      outcome in these sepsis patients. In this prospective Randomized Controlled Trial, the\n      investigators aim to compare high nitrogen intake with conventional nitrogen supply which\n      were recommended in guidelines."
        }, 
        "brief_title": "A Trial to Assess the Effect of High Nitrogen Intake in Patients With Sepsis", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sepsis", 
            "Septic Shock"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Toxemia", 
                "Shock", 
                "Shock, Septic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  sepsis or septic shock\n\n          -  predicted ICU stay more than 7 days\n\n        Exclusion Criteria:\n\n          -  irreversible status of primary disease\n\n          -  any history of malnutrition before enrollment\n\n          -  history of steroid cortisol administration"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02106624", 
            "org_study_id": "HiNiCi"
        }, 
        "intervention": {
            "arm_group_label": [
                "High Nitrogen", 
                "conventional nitrogen"
            ], 
            "description": "Nitrogen supply could be administered through amino acid in parenteral nutrition, proteins in enteral nutrition and IV albumin.", 
            "intervention_name": "nitrogen supply", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "contact": {
                "email": "wu.wei@zs-hospital.sh.cn", 
                "last_name": "Wei Wu, MD", 
                "phone": "8602164041990", 
                "phone_ext": "2324"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200032"
                }, 
                "name": "Division of Critical Care Medicine: Zhongshan Hospital"
            }, 
            "investigator": {
                "last_name": "Ming Zhong, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Efficacy and Safety of High Nitrogen Intake in Patients With Sepsis: a Prospective Randomized and Controlled Trial", 
        "overall_contact": {
            "email": "drnodrab@gmail.com", 
            "last_name": "Ming Zhong, MD", 
            "phone": "8602164041990", 
            "phone_ext": "2724"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "all cause mortality", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "all cause mortality", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02106624"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shanghai Zhongshan Hospital", 
            "investigator_full_name": "Ming Zhong", 
            "investigator_title": "Vice Professor of Division of Critical Care Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "duration on ventilators", 
                "safety_issue": "No", 
                "time_frame": "patients enrolled will be followed for the duration of mechanical ventilation, an expcected average of 4 weeks"
            }, 
            {
                "measure": "ICU stay", 
                "safety_issue": "No", 
                "time_frame": "patients enrolled will be followed for length of ICU stay, an expected average of 6 weeks"
            }, 
            {
                "description": "Details of infection includes pneumonia, catheter-related blood stream infection, urinary tract infect, et al. Diagnosis of infection accords to symptoms, lab tests, imaging measurements and bacterial cultures.", 
                "measure": "infection incidence rate", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "description": "Liver function is assessed through serum bilirubin and liver enzyme, renal function is assessed through serum urea nitrogen and creatinine.", 
                "measure": "Liver function and renal function", 
                "safety_issue": "Yes", 
                "time_frame": "on 1st. day, 3rd. day, 7th. day, 14th. day, 21st. day, 28th. day after enrollment"
            }, 
            {
                "description": "diameter of the muscle is measured with percutaneous ultrasound", 
                "measure": "diameter of midpoint of musculus rectus femoris", 
                "safety_issue": "No", 
                "time_frame": "on 28th. day or endpoint of the trial"
            }, 
            {
                "measure": "serum concentration of albumin, pre albumin, retinaldehyde binding protein, transferrin", 
                "safety_issue": "No", 
                "time_frame": "on 7th. day , 14th. day, 21st. day, 28th. day after enrollment"
            }
        ], 
        "source": "Shanghai Zhongshan Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai Zhongshan Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}